Use of randomly amplified polymorphic DNA markers (RAPD) to demonstrate nosocomial contamination in a case of lethal invasive aspergillosis.
Paugam
A
A
Bougnoux
M E
ME
Robert
F
F
Dupouy-Camet
J
J
Fierobe
L
L
Dhainaut
J F
JF
Girardin
H
H
D000328:Adult; D001228:Aspergillosis / Q000175:diagnosis*; D001232:Aspergillus fumigatus; D001249:Asthma / Q000150:complications; D001992:Bronchoalveolar Lavage Fluid; D003428:Cross Infection / Q000175:diagnosis*; D004271:DNA, Fungal / Q000032:analysis; D005260:Female; D005819:Genetic Markers / Q000235:genetics*; D006801:Humans; D011110:Polymorphism, Genetic; D012128:Respiratory Distress Syndrome / Q000150:complications
D004271:DNA, Fungal; D005819:Genetic Markers